Skip to Content
U.S. National Institutes of Health

NCI R21 Awards in FY2001 in Response to PA-98-042, Exploratory Grants for Collelative Laboratory Studies and Clinical Trials

(PA-98-042 is no longer an active program announcement. It has been superseded by PA-00-047, Quick Trials for Novel Cancer Therapies, and PA-01-010, Exploratory Studies in Cancer Detection, Prognosis and Prediction.)

Would you like more information?

Abstracts of these funded grants are entered in the CRISP (Computer Retrieval of Information on Scientific Projects) database of federally funded biomedical research projects at http://crisp.cit.nih.gov/. This searchable database can be used to retrieve abstracts by grant number, principal investigator or other search terms. It also contains abstracts for grants funded in earlier fiscal years.

Steven P Balk
Invariant NKT Cells for Phase 1 Cancer Trials
Beth Israel Deaconess Medical Center, Boston, MA

Deborah E Banker
Benzodiazepine Receptor and Drug Resistance In AML
Fred Hutchinson Cancer Research Center, Seattle, WA

Hazel B Breitz
Phase I Study of AntiCD20/Streptavidin
Virginia Mason Research Center, Seattle, WA

William E Carson
Correlative Studies for Phase II Trial of IL12 And IFNa
Ohio State University, Columbus, OH

Mark A Exley
CD1d Reactive T Cells In Bone Marrow Transplantation
Beth Israel Deaconess Medical Center, Boston, MA

David D Hurd
Detection of MDS using FISH In Pretransplant Samples
Wake Forest University, Winston-Salem, NC

Neil E Kay
Angiogenesis in B Chronic Lymphocytic Leukemia
Mayo Clinic Rochester, Rochester, MN

Boris Pasche
Mutations of The Type 1 TGF Beta Receptor In Cancer
Northwestern University, Evanston, IL